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S U M M A R Y
Background: The World Health Organization (WHO) ranks respiratory tract infection (RTI) as the second
leading cause of death worldwide for children under 5 years of age. The aim of this work was to evaluate
the epidemiology characteristics of respiratory viruses found in children and adults with RTI from July
2009 to June 2012 in southern China.
Methods: In this work, a total of 14 237 nasopharyngeal swabs (14 237 patients from 25 hospitals) were
analyzed, and seven respiratory viruses (inﬂuenza virus, respiratory syncytial virus, parainﬂuenza virus,
adenovirus, human metapneumovirus, human coronavirus, human bocavirus) were detected using PCR/
RT-PCR from nasopharyngeal swabs.
Results: The demographic characteristics, viral prevalence, age distribution, seasonal distribution, and
pathogen spectrum of the patients with RTIs were analyzed. Co-infection was observed in 483 specimens,
but it was more common in male patients, inpatients, children, and young adults. It varied by season, being
more prevalent in the spring and summer and less so in the winter. Human coronavirus and human
bocavirus were the most common pathogens, tending to occur in co-infection with other respiratory viruses.
Conclusions: This work adds to our knowledge of the epidemiology characteristics of these seven
common respiratory viruses among patients with RTI in southern China. The detection of the speciﬁc
viral causes of infection provides a useful starting point for an understanding of illness attributable to
respiratory infection, and might also provide data relevant to the development of prevention strategies.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Respiratory tract infections (RTI) are a signiﬁcant health burden
for children. The World Health Organization (WHO) estimates that
1.9 million children die each year as a result of the complications of
acute RTIs, mainly pneumonia,1 and 70% of RTI deaths occur in
Africa and southeast Asia.2 The major viral agents of RTI include
inﬂuenza A, B, and C viruses (Flu), respiratory syncytial virus (RSV),
parainﬂuenza virus (PIV), adenovirus (ADV), human metapneu-
movirus (hMPV), human coronavirus (HCoV), and the newly* Corresponding authors.
E-mail addresses: limf@mail.sysu.edu.cn (M. Li), caoky@mail.sysu.edu.cn
(K. Cao).
1 Dingmei Zhang, Zhenjian He and Lin Xu contributed equally to this work.
http://dx.doi.org/10.1016/j.ijid.2014.02.019
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).discovered human bocavirus (HBoV). Flu, RSV, and PIV are often
associated with pneumonia, especially in children under 5 years of
age and those living in developing countries.3–8 In one study of
hospitalized children, RSV was identiﬁed in 15–40% of cases, PIV in
6.8–7%, and Flu in 3%.9 ADV, HCoV, and HBoV are associated with a
substantial proportion of RTI in infants and young children;7,10–12
hMPV has been detected in up to 10% of respiratory specimens.13
RSV and PIV may also contribute substantially to mortality among
the elderly, and the annual outbreaks and recurrent infections
suggest that RSV and PIV may contribute to the burden of disease
throughout life.14,15
The acquisition and spread of RTIs is known to vary among
different study populations in different countries. These variations
may be due to cultural and socioeconomic factors, geographical or
climatic differences, or variations in health care systems. A clear
understanding of the local epidemiology of RTI and the identiﬁcationciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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prevention and control program. Southern China is believed to be
the origin of some important respiratory viruses, such as severe
acute respiratory syndrome coronavirus (SARS-CoV)16 and
inﬂuenza virus.17 Southern China has large populations of
humans and domestic and wild animals, as well as a large
transient population that includes laborers and business people
from different provinces of China and from other countries.
The mixing of these large regional populations may favor the
transmission of respiratory viruses.
The prevalence and clinical presentation of human viral
infections in China have been reported previously.8,10,18–20
However, there are no previously published reports describing
the etiology of the seven common respiratory tract viruses of
inpatient and outpatient RTI across the seasons among the various
age and gender categories. Information on RTI from southern China
is also sparse. To directly address this situation, nasopharyngeal
swabs were collected continuously from children and adults
seeking medical attention for RTI from a total of 25 hospitals in
southern China between July 2009 and June 2012. Seven
respiratory viruses were detected by PCR/RT-PCR and their
epidemiological characteristics were analyzed.
2. Materials and methods
2.1. Ethics issues
All research involving human participants was approved by the
Institutional Review Board of Zhongshan School of Medicine, Sun
Yat-sen University, in accordance with the guidelines for the
protection of human subjects. Participants provided written
informed consent after being briefed on the purpose of the study
and of their right to keep information conﬁdential. Written consent
was obtained from all study participants or their guardians.
2.2. Patients and specimens
Study participants had all been admitted to one of the 25
hospitals covering southern China. Selection criteria included
having one or more respiratory symptoms, such as headache,
cough, expectoration, and pharyngodynia, combined with a body
temperature above 37.5 8C. Symptoms, history of illness, results of
a clinical examination and laboratory tests, and demographic data
were collected for each patient using a standardized form.
Nasopharyngeal swabs were collected according to a standard
procedure, kept in viral transport medium, and stored at 80 8C
prior to analysis (one swab was collected from each patient). For
patients with viral infections, some additional clinical information
was abstracted retrospectively from the medical treatment
records.
2.3. Nucleic acid extraction and cDNA synthesis
DNA or RNA was extracted from 200 ml of the nasopharyngeal
swab specimen using the QIAamp MiniElute Virus Spin kit
(Qiagen). Reverse transcription of virus RNA was conducted using
SuperScript III RT (Invitrogen, Life Technology) in order to detect
RNA viruses (Flu, RSV, PIV, hMPV, and HCoV). DNA samples
extracted using the kit were used directly to detect DNA viruses
(ADV and HBoV). Both kits were used in accordance with the
manufacturer’s instructions.
2.4. Pathogen screening
Flu (A, B, C), RSV, PIV, ADV, hMPV, HCoV, and HBoV were
detected by standard PCR or reverse transcription PCR (RT-PCR), asdescribed previously, using speciﬁc primers listed in the Supple-
mentary Material Table S1,21–25 and ampliﬁed products were
detected using agarose gel electrophoresis.
2.5. Statistical analysis
Statistical analysis was performed using SPSS 13.0 (SPSS Inc.,
Chicago, IL, USA). Viral prevalences were compared using the Chi-
square test for categorical variables, and the cartogram was drawn




A total of 14 237 nasopharyngeal swabs were collected from
July 2009 to June 2012. In all, 7323 specimens were from
outpatients and 6914 specimens were from inpatients. More
specimens were collected from males than from females (ratio
1.48). The median patient age was 21 years (range 0–110 years).
The number of children (age 14 years) was 6117 and the number
of other patients (>14 years) was 8120. The seasonal distribution
of patients sampled was 3756 in spring (January to March), 2617 in
summer (April to June), 3993 in autumn (July to September), and
3871 in winter (October to December). An estimated 99.9% of
eligible patients volunteered to participate. Our data showed a
signiﬁcant difference in inpatient proportion by age, and showed
the difference in sex distribution by age. They did not show the
20–30 and 50–55 years groups, and the relative numbers of male
participants in other age groups were all over 50%.
3.2. Clinical characteristics of the patients
The clinical characteristics of the patients are listed in the
Supplementary Material Table S2. Most patients presented with
symptoms of respiratory tract illness (RTI), including fever
(37.5 8C; 100.0%), cough (84.1%), expectoration (42.1%), runny
nose (36.4%), and sore throat (19.8%).
3.3. Viral prevalence
The total rate of detection of all seven viruses for all specimens
was 39.24% (5582/14 237). Flu viruses were detected in 2632
specimens (18.50%), RSV in 1120 (7.86%), PIV in 494 (3.47%), ADV
in 493 (3.47%), hMPV in 319 (2.24%), HCoV in 351 (2.47%), and
HBoV in 180 (1.26%). The total viral detection rate (all seven
viruses) for all inpatients was 40.01% (2772/6914), which was
higher than that of outpatients (38.47%, 2817/7323) (Chi-square =
3.937, p = 0.047). With the exception of Flu, the viruses were more
common in inpatients than in outpatients (Figure 1). The total viral
detection rate (all seven viruses) was higher in male patients
(40.11%, 3403/8485) than in female patients (37.95%, 2179/5742)
(Chi-square = 6.687, p = 0.010). The rates of detection of RSV, PIV,
and hMPV were higher in male patients than in female patients,
and the detection rate of Flu was lower in male patients than in
female patients (Chi-square = 19.262, p < 0.0001). There was no
difference in the detection rates for ADV, HCoV, and HBoV
(Figure 2).
3.4. Age distribution
A decline in the incidence of viral infections with age was
observed for respiratory viruses, except for Flu. The detection rates
of RSV, PIV, ADV, hMPV, HCoV, and HBoV among children (14
years) were higher than among adults (>14 years old). The
Figure 1. Detection rates of the seven viruses (Flu, RSV, PIV, ADV, hMPV, HCoV, and
HBoV) in outpatients and inpatients (%). Analyses were performed using the Chi-
square test; statistical signiﬁcance is shown with asterisks: *p < 0.05, **p < 0.01. Flu
(Chi-square = 598.226, p < 0.0001), RSV (Chi-square = 450.854, p < 0.0001), PIV
(Chi-square = 17.077, p < 0.0001), ADV (Chi-square = 18.256, p < 0.0001), hMPV
(Chi-square = 59.509, p < 0.0001), HCoV (Chi-square = 59.858, p < 0.0001), and
HBoV (Chi-square = 64.685, p < 0.0001).
Figure 3. Age distribution of the incidence of the seven viruses (Flu, RSV, PIV, ADV,
hMPV, HCoV, and HBoV).
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years old. The detection rate for Flu was highest among patients
aged 15–35 years (Figure 3).
3.5. Seasonal distribution
A combined graph for all three study years showing the
monthly distribution of the seven respiratory viruses was drawn.
The total detection rate of the seven respiratory viruses was
highest in February (48.03%) and August (47.16%), and lowest in
October (23.14%). The highest rate of RSV was detected in February
(16.10%); the highest rate of hMPV was detected in March (4.30%);
PIV, HCoV, and HBoV showed the highest rates of detection in June:
7.87%, 3.68%, and 3.43%, respectively. Flu showed the highest rate
of detection in August (32.03%), and ADV showed the highest rate
of detection in December (4.38%).
The total detection rates for the seven respiratory viruses in
spring, summer, autumn, and winter were 44.31%, 41.15%, 41.66%,
and 30.52%, respectively. The rates of detection were different
during the four seasons (Chi-square = 177.859, p < 0.0001).Figure 2. Detection rates of the seven viruses (Flu, RSV, PIV, ADV, hMPV, HCoV, and
HBoV) in male and female patients (%). Analyses were performed using the Chi-
square test; statistical signiﬁcance is shown with asterisks: *p < 0.05, **p < 0.01).
Flu (Chi-square = 19.262, p < 0.0001), RSV (Chi-square = 30.076, p < 0.0001), PIV
(Chi-square = 11.529, p = 0.001), ADV (Chi-square = 0.312, p = 0.577), hMPV (Chi-
square = 5.195, p = 0.023), HCoV (Chi-square = 2.977, p = 0.084), and HBoV (Chi-
square = 2.176, p = 0.140).However, the detection rates in summer and autumn were similar
(Chi-square = 0.171, p = 0.679). The rates of detection of all viruses
except ADV (Chi-square = 2.170, p = 0.538) differed across the
seasons: Flu (Chi-square = 187.068, p < 0.0001), RSV (Chi-square =
327.662, p < 0.0001), PIV (Chi-square = 32.731, p < 0.0001), hMPV
(Chi-square = 103.609, p < 0.0001), HCoV (Chi-square = 27.864, p <
0.0001), and HBoV (Chi-square = 43.512, p < 0.0001).
In all four seasons, the detection rate of Flu was the highest of
the seven respiratory viruses, followed by RSV. The detection rate
of Flu was highest in autumn and there was no statistically
signiﬁcant difference in rates between spring/summer and
summer/winter. However, the detection rate of RSV was highest
in spring. The detection rate for PIV was highest in summer. There
was no difference in the rate of detection of PIV during spring,
autumn, and winter. For hMPV, the detection rates during spring
and summer were higher than during autumn and winter. There
was no difference between spring/summer and autumn/winter.
The detection rate for HCoV was lowest in autumn; there was no
difference among spring, summer, and winter. The detection rate
for HBoV was lower in spring than in summer, autumn, and winter.
3.6. Pathogen spectrum
The pathogen spectrum differed with patient age. The propor-
tion of patients infected with Flu increased with age, peaking in the
group including age 15 years (86.31%), after which it ﬂuctuated
slightly but remained stable, and declined signiﬁcantly after age 60
years. However, the rates of detection of RSV, PIV, ADV, hMPV, and
HCoV relative to the total rate of detection decreased after the
patients reached adulthood, and then ﬂuctuated only slightly until
age 60 years, after which they declined signiﬁcantly.
RSV was the most common pathogen detected in children,
accounting for 31.72% of all viruses detected in children. Flu
accounted for 25.91% of all the viruses detected in children. Flu was
the most common pathogen detected in adults, accounting for
74.97% of all viruses detected. Flu was the most common pathogen
detected in outpatients (68.25%). RSV was the most common
pathogen detected in inpatients (31.78%). However, RSV was the
most common pathogen detected in inpatient children (34.77%).
Flu was the most common pathogen detected in inpatient adults
(81.04%), outpatient children (34.46%), and outpatient adults
(42.02%).
The proportion of Flu infections among female cases (53.33%)
was greater than among male cases (43.20%). However, there were
fewer RSV, PIV, HCoV, and hMPV among female cases than among
male cases. The pathogen spectrum also differed across the
seasons. RSV accounted for a larger proportion of the total number
Figure 4. Rates of detection of the seven viruses (Flu, RSV, PIV, ADV, hMPV, HCoV, and HBoV) by season. The percentages were calculated as the total number of virus-positive
cases for the individual virus divided by the number of cases positive for one of the seven viruses in the same season.
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accounted for a larger proportion during summer (12.92%,
9.01%, and 5.11%, respectively). Flu accounted for a larger
proportion during autumn (61.23%). ADV and HCoV accounted
for a larger proportion during winter (11.35% and 9.99%,
respectively) (Figure 4).
3.7. Co-infections of respiratory virus
Co-infections occurred in 483 specimens, with detection rates
of 3.39% (483/14 237) of all specimens and 9.55% (483/5057) of
positive specimens. Among the 483 co-infected specimens, 442
were double infections, 40 were triple infections, and one was a
quadruple infection (Table 1). The one quadruple infection was in a
1-year-old girl (born April 25, 2010), residing in the Liwan region of
Guangzhou city. She was admitted to the hospital on April 26,
2011. The symptoms included fever (39.5 8C), cough, runny nose,
and expectoration, with a diagnosis of bronchopneumonia.
Mycoplasma pneumoniae and Chlamydophila pneumoniae were also
detected. Co-infection viruses included Flu, RSV, HCoV, and HBoV,
at rates of 52.17% (252/483), 50.52% (244/483), 39.03% (137/351),
and 36.67% (66/180), respectively.
Flu and RSV were frequently detected as co-infection viruses
among the 483 co-infection specimens, accounting for 52.17%
(252/483) and 50.52% (244/483), respectively. However, HCoV and
HBoV were the pathogens preferring to co-infect with other
respiratory viruses; 39.03% (137/351) of HCoV-positive samplesand 36.67% (66/180) of HBoV-positive samples were found to
contain other respiratory viruses.
Most co-infected patients were male (66.05%, 319/483),
inpatients (69.15%, 334/483), children <4 years old (67.07%,
324/483), and younger adults aged 20–35 years (12.84%, 62/483).
Co-infection was more common in children 14 years old, (6.02%)
than in adults (>14 years old; 1.42%) (Chi-square = 225.195, p <
0.0001). The rate of co-infection detection was 3.76% (319/8490) in
male patients and 2.85% (164/5747) in female patients (Chi-square
= 8.540, p = 0.003), and 2.03% (149/7323) in outpatients and 4.83%
(334/6914) in inpatients (Chi-square = 84.833, p < 0.0001).
There were 175, 121, 113, and 74 cases of co-infection in spring,
summer, autumn, and winter, respectively; the co-infection rates
were 4.66%, 4.63%, 2.83%, and 1.91%, respectively (Chi-square =
60.209, p < 0.0001). The co-infection rates in spring and summer
were higher than in autumn and winter, and the rate of co-
infection in winter was the lowest.
4. Discussion
The WHO ranks RTI as the second leading cause of death
worldwide for children younger than 5 years of age.26 However,
the inﬂuenza viruses are the only viral respiratory pathogens for
which vaccines are currently available.27 Ongoing vaccine research
and development are focusing on many other leading viral
pathogens.27–29 The detection of the speciﬁc viral causes of
infection provides a useful starting point for an understanding of
Table 1
























FluA, RSV, PIV 5
FluA, RSV, ADV 1
FluA, RSV, hMPV 1
FluA, RSV, HCoV 6
FluA, PIV, ADV 2
FluA, PIV, HCoV 2
FluA, hMPV, HCoV 2
FluA, HCoV, HBoV 1
RSV, PIV, ADV 2
RSV, PIV, hMPV 4
RSV, PIV, HCoV 2
RSV, PIV, HBoV 2
RSV, ADV, HCoV 2
RSV, ADV, HBoV 2
RSV, hMPV, HBoV 1
RSV, HCoV, HBoV 2
PIV, ADV, hMPV 2
PIV, ADV, HCoV 2
PIV, ADV, HBoV 1
ADV, hMPV, HCoV 1
ADV, hMPV, HBoV 1
Flu, RSV, PIV, HCoV 1
Flu, inﬂuenza virus; RSV, respiratory syncytial virus;
PIV, parainﬂuenza virus; ADV, adenovirus; hMPV,
human metapneumovirus; HCoV, human coronavirus;
HBoV, human bocavirus.
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relevant to the development of prevention strategies. The objective
of the study was to estimate the prevalence of respiratory viruses
in people who presented with acute respiratory tract infections in
southern China over a 3-year study period.
Human PIV is a major cause of respiratory tract illness in infants
and young children worldwide.30 All children experience at least
one PIV infection by the age of 5 years, and re-infection may occur
throughout life because of incomplete immunity.31 The virus is
associated with a wide variety of RTIs, but most frequently with
croup and pneumonia. Annual epidemics of hPIV-3 infection are
responsible for considerable economic losses as a result of
hospitalization, medication costs, work and school absence, and
mortality. However, PIV infections have been less well studied
compared to RSV and inﬂuenza viral infections. In the present
study, PIV was associated with 10.00% of all the RTI hospitaliza-
tions and 15.00% of the RTI in outpatient children. A study in the
USA found PIV infections to be associated with 11.50% of all
pediatric RTI hospitalizations.32
Human bocavirus (HBoV) was ﬁrst reported by Allander et al. in
2005.33 Subsequently, HBoV was reported in respiratory specimenscollected from different countries and regions worldwide,34–36 and
detected in 1.50% to 8.30% of respiratory specimens from individuals
with acute RTI, especially young children and infants. In the present
study, HBoV was detected in 3.85% of all children <2 years old, who
provided 78.33% of all the HBoV-positive specimens. HBoV infection
has recently attracted attention worldwide. However, the incidence
and clinical presentation of this infection varies widely, often
involving co-infection with other potential pathogens.37 Such
characteristics have led to debate over the role of HBoV as a true
pathogen. In the present study, among the 180 HBoV-positive
specimens, there were 66 (36.67%) co-infections with at least
one other respiratory virus. Elderly people have also been reported
to be susceptible to HBoV. A single lineage of HBoV was detected
among a wide age distribution of patients with acute RTI. In this
study, a total of 18 adult specimens were positive for HBoV. The virus
has also been found in stool specimens from patients with
gastrointestinal illness.38,39 Therefore, additional evidence and
studies are needed throughout the world to gain a better
understanding of this virus.
This study adds to the knowledge of seasonal variations of
respiratory viral infections in southern China. The epidemiology of
respiratory viral infection was found to vary tremendously by
geographical region. In temperate climates, the prevalence of these
viruses is well documented as a cause of yearly winter epidemics of
acute lower RTIs.40 This study clearly showed evidence of seven
viruses throughout the 3-year study period. The highest rate of
infection was in spring, with a peak in February (48.03%), and the
lowest rates of infection were in winter, with a nadir in October
(23.14%), which may be attributed to the fact that February is the
coldest month in southern China. The detection rates for summer
and autumn were similar and this is likely due to high humidity and
a lack of signiﬁcant delimitation between summer and autumn.
With recent advances in the detection of respiratory agents,
numerous studies have shown that some pediatric patients with
acute lower RTIs become infected simultaneously with multiple
respiratory viruses.41,42Multiple viral infections have been linked in
some reports to higher fever, a longer hospital stay, more frequent
use of antibiotics, and an increased risk of admission to the ICU.43
However, there is no consensus regarding the effect of co-infection
on the severity of disease. The effect may depend upon which viruses
co-infect.44 In the present study, 3.39% of specimens had multiple or
dual infections, with a predominance of Flu compared to the other
co-viruses. However, in the positive specimens, the co-infection
rates for HCoV and HBoV were higher than those of other respiratory
viruses. The co-infection rates were higher in male patients,
inpatients, and patients aged 14 years. The rates of co-infection
were higher during spring and summer than during autumn and
winter. The rates of co-infection were lowest during winter, which
corresponded with the overall low detection rates in winter.
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